Interferon treatment of children with chronic hepatitis C

Hepato-Gastroenterology

Volumn 45, Issue 20, 1998, Pages 345-348

  Al Tawil, Youhanna ^a   Nelson, Chris ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Children; Hepatitis C; Interferon

Indexed keywords

ALANINE AMINOTRANSFERASE; RECOMBINANT ALPHA INTERFERON; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER TRANSPLANTATION; MEDICAL LITERATURE; PRIORITY JOURNAL; SHORT SURVEY; SIDE EFFECT;

ANTIVIRAL AGENTS; CHILD; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA;

EID: 0031971512     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (39)

1. Han JH, Shyamala V, Richman KH et al: Characterization of the terminal regions of hepatitis C viral RNA: Identification of conserved sequences in the 5′ untranslated region an poly (A) tails at the 3′ end. Proc Natl Acad Sci USA 1991; 88:1711-1715.
2. Locasciulli A, Gornati G, Tagger A et al: Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission. Blood 1991; 78:1619-22.
3. Puchhammerstockl E, Hofmann H, Fink FM et al: Prevalence of hepatitis C virus infection in children with chronic post-transfusion hepatitis. J Med Virol 1992; 37:298-302.
4. Resti M, Azzari C, Rossi ME, Vullo C, Zammarchi E, Vierucci A: Hepatitis-C virus antibodies in a long-term follow-up of beta thalassemic children with acute and chronic non-A, non-B hepatitis. Eur J Pediiatr 1992; 151:573-6.
5. Jonas MM, Zilleruelo GE, LaRue SI et al: Hepatitis C infection in a pediatric dialysis population. Pediatrics 1992; 89:707-9.
6. Rossetti F, Cesaro S, Pizzochero P, Cadrobbi P, Guido M, Zanesco L: Chronic hepatitis B surface antigen-negative hepatitis after treatment of malignancy. J Pediatr 1992; 121:39-43.
7. Vranchx R, Van Damme P: Hepatitis C in institutionalized children. N Engl J Med 1990; 323:64.
8. Alter JH: Chronic sequences of non-A, non-B hepatitis. In Seeff LB, Lewis JH (eds): Current Perspectives in Hepatology. New York, Plenum, 1989; pp83-97.
9. Iorio R, Guida S, Porzio S, Fariello I, Vegnente A: Chronic non-A, non-B hepatitis: role of hepatitis C virus. Arch Dis Child 1993; 68:219-22.
10. Bortolotti F, Jara P, Diaz C, Vajro P, Hierro L, Giacchino R, De la Vega A et al: Posttransfusion and community-acquired hepatitis C in childhood. J Pediatr Gastroenterol Nutr 1994; 18:279-283.
11. Iorio R, Guida S, Porzio S, Fariello I, Vegnente A: Chronic non-A, non-B hepatitis: role of hepatitis C virus. Arch Dis Child 1993; 68:219-22.
12. Lau JYN, Mizokami M, Chno T et al: Discrepancy between biochemical and virologie responses to interferon therapy in patients with chronic hepatitis C. Lancet 1993; 342:1208-9.
13. Krawszynski M, Tankersley D, Robertson B, Lambert S, Speibring J, Meeks E, Sinha S, Carson D et al: Effect of Immune Globulin on the Prevention of Experimental Hepatitis C Virus Infection. Infec & Dis ?Year - Author please supply 822-827.
14. Pagliaro L, Craxi A, Camma C et al: Interferon-alfa for chronic hepatitis C: an analysis of pretreatment clinical predictors of response. Hepatology 1994; 19:820-8.
15. Tsubota A, Chayama K, Ikeda K et al: Factors predictive of response to interferon-alfa therapy in hepatitis C virus infection. Hepatology 1994; 19:1088-94.
16. Iorio R, Pensati P, Porzio S, Fariello I, Guida S, Vegnente A: Lymphoblastoid interferon alfa treatment in chronic hepatitis C. Arch Dis Child 1993; 74:152-156.
17. Ruiz-Moreno M, Rua MJ, Castillo I et al: Treatment of children with chronic hepatitis C with recombinant interferon-alfa: a pilot study. Heptology 1992; 16:882-5.
18. Bortolotti F, Giacchino R, Vajro P, Barbera C, Crivellaro C, Alberti A, Gabriella N, Zancan L, De Moliner L, Bertolini A, Balli F, Callea F: Recombinant interferon-alfa therapy in children with chronic hepatitis C. Hepatology 1995; 22(6):1623-1627.
19. Fujisawa T, Inui A, Ohkawa T, Komatsu H, Miyakawa Y, Onoue M: Response to interferon therapy in children with chronic hepatitis C. J Pediatr 1995; 127:660-2.
20. Nour B, Tzakis A, Van Thiel D: The Use of Interferon for the treatment of viral hepatitis in pediatric liver transplant recipients; J of Oklahoma state Med Assoc 1995; 88(3).
21. Cook GC, Mulligan R, Sherlock S: Controlled prospective trial of corticosteriod therapy in active chronic hepatitis. QJ Med 1971; 158:159-85.
22. Soloway RD, Summerskill WHJ, Baggenstoss AH et al: Clinical, biochemical and histological remission of severe chronic active liver disease: A controlled study of treatments and early prognosis. Gastroenterology 1972; 63:820-33.
23. Murray-Lyon IM, Stern RB, Williams R: Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet 1973; (I):735-7.
24. Thiele D, DuCharme L, Cunningham M, Mimms L, Cuthbert J, Lee W, Combes B: Steroid therapy of chronic hepatitis: Characteristics associated with response in anti-hepatitis C virus-positive and negative patients. AJG; 91(2):300-213.
25. Reichard O, Andersson J, Schvarcz R et al: Ribavirin treatment for chronic hepatitis C. Lancet 1991; 337:1058-1061.
26. Di Bisceglie AM, Shindo M, Fong TL et al: A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology 1992; 16:649-654.
27. Camps J, Garcia N, Riezu-Boj JI et al: Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon. J Hepatol 1993; 19:408-412.
28. Reichard O, Yun ZB, Sonnerborg A et al: Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C. J Med Virol 1993; 41:99-102.
29. Di Bisceglie AM, Hoofnagle JH, Krawczynski K Koskinas J, Tibbs C, Saleh MG et al: Changes in hepatitis C virus antigen. Effects of ribavirin on intrahepatic and extrahepatic expression of hepatitis C virus in interferon nonresponsive patients. J Med Virol 1995; 45:29-34.
30. Koskinas J, Tibbs C, Saleh MG et al: Effects of ribavirin on intrahepatic and extrahepatic expression of hepatitis C virus in interferon nonresponsive patients. J Med Virol 1995; 45:49-34.
31. Daoud S, Garnier JL, Chossegros P et al: Hepatitis C virus infection in renal transplantation. Transplant Proc 1995; 27:1735
32. Reichard O: Treatment of chronic hepatitis C. Scand J Infect Dis (Supplementum) 1994; 95:1-56.
33. Kakumu S, Yoshioka K, Wakita T et al: A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C. Gastroenterology 1993; 105:507-512.
34. Lai M, Kao J, Yang P, Wang J, Chen P, Chan K, Shu J, Chen D: Long-term Efficacy of Ribavirin Plus Interferon Alfa in the treatment of Chronic Hepatitis C. Gastroenterology 1996; 111:1307-1312.
35. Konig V, Bauditz J, Lobeck H et al: Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology 1992; 16:1137-43.
36. Thung SN, Shim KS, Shieh YCS et al: Hepatitis-C in liver allografts. Arch Pathol Lab Med 1993; 1997:145-9.
37. Gane E, Portmann B, Naoumov N, Smith H, Underbill J, Donaldson P, Maertens G, Williams R: Long-Term outcome of Hepatitis C infection after liver transplantation. N Engl J of Med 1996; 334:815-820.
38. Zuckerman A, Zuckerman J: Prospects for hepatitis C vaccine. Hepatology 1995; 22:97-100.
39. Alter HJ: Hepatitis C: natural history. In: Wright T, Bodenheimer HC, eds. Postgraduate Course Syllabus. Thorofare, NJ: American Association for the Study of Liver Disease 1994; 225-245.